Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-03

Clinical Trial Update: Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate

View source ↗

Summary

A non-interventional study of people newly diagnosed with schizophrenia treated with paliperidone palmitate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVEGA SUSTENNA (PALIPERIDONE PALMITATE)
  • Paliperidone palmitate (Paliperidone palmitate)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Schizophrenia | Status: COMPLETED